Evidence map›Paper›PMID 26981582›Full record

ArticleEBioMedicine2016

Enabling Precision Medicine With Digital Case Classification at the Point-of-Care.

Patrick Obermeier, Susann Muehlhans, Christian Hoppe, Katharina Karsch, Franziska Tief, Lea Seeber, Xi Chen, Tim Conrad, Sindy Boettcher, Sabine Diedrich and 1 more

Abstract read
In one paragraph

Article in EBioMedicine, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. SARS-CoV-2 saliva testing using RT-PCR: a systematic review.International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases · 2022
    Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Rapid Evaluation of the XpertDiagnostics (Basel, Switzerland) · 2022
    Article
  7. Article
  8. Article
  9. Article
  10. Pathogens (Basel, Switzerland) · 2022
    Article
  11. Article
  12. Article
  13. Article
  14. Vienna Vaccine Safety Initiative.Human vaccines & immunotherapeutics · 2018
    Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors.

Patrick ObermeierDepartment of Pediatrics, Charité University Medical Center Berlin, Germany; Vienna Vaccine Safety Initiative, Berlin, Germany.
Susann MuehlhansDepartment of Pediatrics, Charité University Medical Center Berlin, Germany; Vienna Vaccine Safety Initiative, Berlin, Germany.
Christian HoppeDepartment of Pediatrics, Charité University Medical Center Berlin, Germany; Vienna Vaccine Safety Initiative, Berlin, Germany.
Katharina KarschDepartment of Pediatrics, Charité University Medical Center Berlin, Germany.
Franziska TiefDepartment of Pediatrics, Charité University Medical Center Berlin, Germany; Vienna Vaccine Safety Initiative, Berlin, Germany.
Lea SeeberDepartment of Pediatrics, Charité University Medical Center Berlin, Germany; Vienna Vaccine Safety Initiative, Berlin, Germany.
Xi ChenDepartment of Pediatrics, Charité University Medical Center Berlin, Germany; Vienna Vaccine Safety Initiative, Berlin, Germany.
Tim ConradDepartment of Mathematics and Computer Sciences, Free University Berlin, Germany.
Sindy BoettcherNational Reference Centre for Poliomyelitis and Enteroviruses, Robert Koch Institute, Berlin, Germany.
Sabine DiedrichNational Reference Centre for Poliomyelitis and Enteroviruses, Robert Koch Institute, Berlin, Germany.
Barbara RathDepartment of Pediatrics, Charité University Medical Center Berlin, Germany; Vienna Vaccine Safety Initiative, Berlin, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Infectious and inflammatory diseases of the central nervous system are difficult to identify early. Case definitions for aseptic meningitis, encephalitis, myelitis, and acute disseminated encephalomyelitis (ADEM) are available, but rarely put to use. The VACC-Tool (Vienna Vaccine Safety Initiative Automated Case Classification-Tool) is a mobile application enabling immediate case ascertainment based on consensus criteria at the point-of-care. The VACC-Tool was validated in a quality management program in collaboration with the Robert-Koch-Institute. Results were compared to ICD-10 coding and retrospective analysis of electronic health records using the same case criteria. Of 68,921 patients attending the emergency room in 10/2010-06/2013, 11,575 were hospitalized, with 521 eligible patients (mean age: 7.6 years) entering the quality management program. Using the VACC-Tool at the point-of-care, 180/521 cases were classified successfully and 194/521 ruled out with certainty. Of the 180 confirmed cases, 116 had been missed by ICD-10 coding, 38 misclassified. By retrospective application of the same case criteria, 33 cases were missed. Encephalitis and ADEM cases were most likely missed or misclassified. The VACC-Tool enables physicians to ask the right questions at the right time, thereby classifying cases consistently and accurately, facilitating translational research. Future applications will alert physicians when additional diagnostic procedures are required.

Indexed as

Medical Records Systems, ComputerizedPoint-of-Care SystemsSoftwareHumansMedical RecordsPrecision MedicineADEMData standardsEncephalitisMeningitisMobile healthSurveillance

Identifiers

PMID26981582
PMCPMC4776059

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.